RCP appoints Professor Volmar Weissig to scientific advisory board
This article was originally published in Scrip
RCP Therapeutics, a US biopharmaceutical company specialising in the converging nanotechnology and regenerative medical markets, has appointedProfessor Volkmar Weissig to its scientific advisory board. Professor Weissig is associate professor of pharmacology at the department of pharmaceutical sciences, Midwestern University College of Pharmacy, Glendale, Arizona.
You may also be interested in...
The Democratic Primary focused heavily on the idea of ‘Medicare for All,’ but the emergence of former Vice President Biden as the party standard bearer – and the overwhelming impact of the COVID-19 outbreak – suggests a very different theme for the national campaign.
In a 1 June speech before the Alliance For a Stronger FDA, US FDA commissioner Stephen Hahn stressed the agency’s vigilance in guarding against consumer use of flawed COVID-19 products. He also made comments about the need for doctors to communicate more with patients. See what he said about the use of telehealth here.
Request for documents and a briefing is part of efforts to ensure federal programs are ‘protected from price gouging.’